These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26055103)

  • 21. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients.
    Sardo MA; Mandraffino G; Riggio S; D'Ascola A; Alibrandi A; Saitta C; Imbalzano E; Castaldo M; Cinquegrani M; Saitta A
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):933-8. PubMed ID: 20497421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of antihypertensive effect of angiotensin II receptor blockers in patients with essential hypertension by self-measured home blood pressure--HACARARE 300 study].
    Msanobu T;
    Nihon Rinsho; 2009 Oct; 67(10):2013-20. PubMed ID: 19860206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy.
    Oshikawa J; Toya Y; Morita S; Taguri M; Hanaoka K; Hasegawa T; Kaizu K; Kamata K; Kobayashi S; Ohtake T; Sato T; Yasuda G; Kimura K; Umemura S
    Clin Exp Hypertens; 2014; 36(4):244-50. PubMed ID: 23848219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF; Gerocarni B; Rosticci M; Borghi C
    Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
    Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose and very low-dose spironolactone in combination therapy for essential hypertension: evaluation by self-measurement of blood pressure at home.
    Hanazawa T; Obara T; Ogasawara K; Shinki T; Katada S; Inoue R; Metoki H; Asayama K; Kikuya M; Ohkubo T; Mano N; Imai Y
    Clin Exp Hypertens; 2011; 33(7):427-36. PubMed ID: 21777149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.
    Zannad F; Fay R
    Fundam Clin Pharmacol; 2007 Apr; 21(2):181-90. PubMed ID: 17391291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension].
    Minami J; Ishimitsu T; Matsuoka H
    Nihon Jinzo Gakkai Shi; 2005; 47(8):864-9. PubMed ID: 16408430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive drug reduction for treated hypertensive patients during the summer.
    Arakawa K; Ibaraki A; Kawamoto Y; Tominaga M; Tsuchihashi T
    Clin Exp Hypertens; 2019; 41(4):389-393. PubMed ID: 29939771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Summer Dizziness" as a Neglected Phenomenon of Antihypertensive Drug Overuse in Patients With Carotid Disease: A Hypothesis.
    Radak D; Tanaskovic S
    Angiology; 2016 Oct; 67(9):797-8. PubMed ID: 26656500
    [No Abstract]   [Full Text] [Related]  

  • 40. Summertime, wintertime, a biannual shift or what? : A polylemma!
    Kundi M
    Wien Klin Wochenschr; 2024 Jul; 136(13-14):373-374. PubMed ID: 38277025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.